70/73
  • Pages
  • Editions
01 Cover
02 Welcome Letter / Sections
03 Article & Interview Directory
04 Section 1: Introduction
05 Introduction to US Life Sciences
06 Janssen Pharmaceuticals Interview
07 Investment Climate
08 MPM Capital Interview
09 Signet Healthcare Partners Interview
10 Xontogeny Interview
11 Insights from EisnerAmper
12 The Life Sciences Regulatory Climate
13 Buchanan Ingersoll & Rooney PC Interview
14 PhRMA Interview
15 PBOA Interview
16 Ernst & Young LLP Interview
17 LaVoieHealthScience Interview
18 Section 2: Introducing the Hubs
19 East Coast
20 BioNJ Interview
21 MassBio Interview
22 Pennsylvania Biotechnology Center Interview
23 West Coast
24 Biocom California Interview
25 QB3-Berkeley Interview
26 Section 3: Drug Discovery and Development
27 Therapeutic Fields On Fire
28 Insmed Interview
29 Mammoth Biosciences Interview
30 Innovations Enhancing the Patient Experience
31 Arcturus Therapeutics Interview
32 Karius Interview
33 Expert Insights: Targeted Therapeutics
34 First Wave BioPharma Interview
35 Aphios Corporation Interview
36 Section 4: Contract Manufacturing and Chemicals
37 A Shifting Landscape
38 Syngene International Interview
39 Cambrex Interview
40 Lubrizol Life Science Interview
41 Aenova Group Interview
42 Keeping Up With Demands
43 Cureline Interview
44 Interview: Murli Krishna Pharma
45 PsychoGenics Interview
46 Expert Insights: Innovative Technologies
47 AMPAC Fine Chemicals Interview
48 TCG Lifesciences Interview
49 CordenPharma Interview
50 Quotient Sciences Interview
51 A Post-Pandemic World
52 New Vision Pharmaceuticals Interview
53 Adare Pharma Solutions Interview
54 Ascendia Pharmaceuticals Interview
55 Chemicals Producers and Distributors
56 Brenntag North America Interview
57 BASF Pharma Solutions Interview
58 Section 5: Technology Services
59 Life Sciences Go Digital
60 RxS Interview
61 Insights from Markem-Imaje
62 AiCure Interview
63 WhizAI Interview
64 Section 6: Company Profiles
65 Brenntag Company Profile
66 Adare Pharma Solutions Company Profile
67 Quotient Sciences Company Profile
68 SK pharmteco Company Profile
69 AiCure Company Profile
70 Markem-Imaje Company Profile
71 TCG Lifesciences Company Profile
72 Murli Krishna Pharma Company Profile
73 Credits

COMPANY PROFILE


“We've been defining what's possible in coding for decades through superior technology, implementation, and services. With technical leadership in the implementation of coding hardware and software, and the broadest global network coverage in the industry, we can meet all needs, from local producers to global companies, and from end users to system integrators.”

Summary


Systech solutions by Markem-Imaje provide packaging and industrial coding, product authentication and traceability solutions to help our customers optimize processes, achieve compliance and combat supply chain threats. Built on decades of Systech experience as the leader in pharmaceutical serialization and Markem-Imaje’s trusted product identification expertise, our comprehensive brand protection and packaging intelligence suites deliver accurate, real-time insight, actionable product data and digital connectivity.

In 2007, the American company Markem and the French company Imaje merged, and the new company Markem-Imaje was born. In 2020, Systech joined Markem-Imaje to deliver comprehensive packaging intelligence solutions that protect products from the factory floor to the consumer.

Key Leadership


• Vincent Vanderpoel, CEO

• Tim Gliffe, VP Sales

• Mark Rapposelli, VP Research and Development

• Sabine Gattolliat, VP Human Resources

• Rizwan Malik, CFO

Primary Products/Services


Markem-Imaje is a global manufacturer of product identification and traceability solutions. Our connected solutions help manufacturers reduce waste, increase efficiency, comply with regulations and protect their brand.

Additional Resources


About Markem-Imaje

Markem-Imaje Blog

Dover Corporation

Contact

Twitter

LinkedIn

Website

Next:

Company Profile: TCG Lifesciences